UC AKT.ANL. 12/24 OMV/ DE000HD1QPA9 /
2024-09-18 9:01:21 AM | Chg.+0.150 | Bid9:20:35 AM | Ask9:20:35 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
97.860EUR | +0.15% | 97.930 Bid Size: 225,000 |
98.040 Ask Size: 225,000 |
OMV AG | 38.0081 EUR | 2024-12-31 | Call |
GlobeNewswire
03-26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
01-16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
2023-09-14
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
2021-10-13
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center